PRODUCT AND METHOD FOR MUCUS VISCOSITY NORMALIZATION Russian patent published in 2021 - IPC A61K38/46 A61P11/12 

Abstract RU 2750211 C2

FIELD: medicine; therapy.

SUBSTANCE: group of inventions can be used to reduce mucus viscoelasticity or sputum in a patient with excessively viscous or sticky mucus or sputum. For this purpose, mucus or sputum of said patient is brought into contact with a composition containing a protein or peptide containing a mono-cystine active center of thioredoxin in a reduced state, wherein the thioredoxin mono-cystine active center comprises an amino acid sequence selected from a group consisting of C-X-X-S (SEQ ID NO: 24), C-X-X-X (SEQ ID NO: 17), X-C-X-X-X-X (SEQ ID NO: 19), X-C-G-P-X-X (SEQ ID NO: 21), W-C-G-P-X-K (SEQ ID NO: 23), X-C-X-X-S-X (SEQ ID NO: 25), X-C-G-P-S-X (SEQ ID NO: 26) and W-C-G-P-S-K (SEQ ID NO: 27), wherein said residue C is in a reduced state, wherein said residues X are any amino acid residue other than cysteine. Also disclosed are methods, pharmaceutical compositions and use thereof for converting a disulphide bond of a target protein into a stable mixed disulphide bond, to maintain stable mixed disulphide bond, for its conversion into stable mixed disulphide bond.

EFFECT: group of inventions makes it possible to increase effectiveness of mucus or sputum liquefaction due to covalent binding with mucin cysteine at safety and good tolerance.

49 cl, 3 dwg, 3 tbl, 9 ex

Similar patents RU2750211C2

Title Year Author Number
MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO THE THIOREDOXIN-1 EPITOPE, ITS PREPARATION AND APPLICATION 2018
  • So Ken Khun
  • Kim De Chzhun
  • Kim En
  • Kim Mi Ken
  • Chon Chzhon Khvan
  • Li Ki Se
RU2791264C2
THIOREDOXIN-1 EPITOPE BINDING SPECIFICALLY TO MONOCLONAL ANTIBODY 2018
  • Suh Kyong Hoon
  • Kim Dae Joong
  • Kim Young
  • Kim Mi Kyung
  • Jung Jong Hwan
  • Lee Ki Se
RU2804772C2
THIOREDOXIN-1 EPITOPE BINDING SPECIFICALLY TO MONOCLONAL ANTIBODY 2018
  • Suh Kyong Hoon
  • Kim Dae Joong
  • Kim Young
  • Kim Mi Kyung
  • Jung Jong Hwan
  • Lee Ki Se
RU2804126C2
THIOREDOXIN-1 EPITOPE BINDING SPECIFICALLY TO MONOCLONAL ANTIBODY 2023
  • Suh Kyong Hoon
  • Kim Dae Joong
  • Kim Young
  • Kim Mi Kyung
  • Jung Jong Hwan
  • Lee Ki Se
RU2802944C1
THIOREDOXIN-1 EPITOPE AND MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO IT 2018
  • Suh Kyong Hoon
  • Kim Dae Joong
  • Kim Young
  • Kim Mi Kyung
  • Jung Jong Hwan
  • Lee Ki Se
RU2797266C2
MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO THE THIOREDOXIN-1 EPITOPE, ITS PREPARATION AND APPLICATION 2018
  • Suh Kyong Hoon
  • Kim Dae Joong
  • Kim Young
  • Kim Mi Kyung
  • Jung Jong Hwan
  • Lee Ki Se
RU2790687C2
PROTEIN AND VACCINE AGAINST SARS-CoV-2 INFECTION 2020
  • Vej, Syavej
  • Lu, Guanven
  • Van, Vej
  • Yan, Tszinlyan
  • Yan, Li
  • Li, Tszyun
  • Yan, Tszinyun
  • Vej, Yujtsyuan
  • Van, Chzhenlin
  • Chzhao, Chzhivej
  • Shen, Gobo
RU2815060C1
MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THIOREDOXIN-1 AND ITS USE 2016
  • Suh, Kyong Hoon
  • Kang, Eun Hye
  • Kim, Il Han
  • Jung, Jong Hwan
  • Lee, Ki Se
  • Kim, Mi Kyung
RU2747929C2
IMPROVED IMMUNOGENICITY OF L2 HPV PEPTIDE 2017
  • Bolchi, Andzhelo
  • Myuller, Martin
  • Ottonello, Simone
  • Pujyanfard, Somaje
  • Spanoli, Gloriya
RU2743016C2
CYCLIC PROTEIN CONTAINING NO CYSTEINE RESIDUES 2008
  • Fisher Vernkhard
  • Lukas Rudol'F
RU2486196C2

RU 2 750 211 C2

Authors

Khejfetts Piter B.

Dates

2021-06-24Published

2014-03-17Filed